FDA
-
-
-
-
-
-
-
Quantum BioPharma submits IND application to FDA for MS drug trial
-
-
-
-
-
-
-
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication
-
-
-
-
-
-
-
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial
-
-
-
-
-
-
-
Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid
-
-
-
-
-
-
-
Quantum BioPharma (QNTM) Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South A
-
-
-
325,419 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

